I still think the single biggest risk is that of trial failure...but without the do re mi to get to the finish line Apabetalone can't achieve either success or failure.
I've done a fair bit of reading on success rates for drug trials and it seems the biggest drop off is in ph II with only something like 35% or so of drugs advancing to phase III. Then success in phase III is something close to 60% but those numbers are dragged down by cancer drugs which apparently have a much higher failure rate. Get to an NDA and the numbers I'm seeing suggest 90% approval.
Interestingly RVXCF traded higher at the opening while RVX went down....
I think we're going to be seeing lots more news in the coming weeks.
If you want to taste the fruit, you have to go out on a limb. But if you wait for the herd to move out on the limb....the branch tends to snap.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM